Sector News

Ferring buys BioSET’s orthobiologics

February 19, 2015
Life sciences
Ferring Pharmaceuticals has acquired the assets of the USA’s BioSurface Engineering Technologies (BioSET), including two Phase III-ready ‘orthobiologics’ designed to improve bone repair.
 
The candidates in question, Amplex and Prefix, are based on “a unique biomimetic peptide designed to enhance the body’s own natural mechanisms of bone repair”, Ferring says. They will be investigated for fusion in foot/ankle and lumbar spine surgical procedures, respectively.
 
Orthopaedics has become a key area for Ferring since the 2005 launch of Euflexxa (1% sodium hyaluronate) for knee pain and buying the BioSET portfolio builds on that. Chief operating officer Michel Pettigrew said that “by developing new orthobiologic products for joint fusion, we will expand and diversify our offering to include innovative solutions for orthopaedic surgery”.
 
No financial terms have been disclosed. Switzerland-headquartered Ferring noted that each year some two million procedures involving bone graft materials, including 700,000 fusions, are performed in the USA alone.
 
By Kevin Grogan
 
Source: Pharma Times

Related News

February 28, 2021

UCB taps Microsoft to accelerate drug discovery, clinical trials

Life sciences

The deal will see Microsoft use its capabilities in computational services, cloud computing and artificial intelligence to support drug discovery and development at UCB.

February 28, 2021

GSK to close two UK antibiotics manufacturing sites

Life sciences

The planned closures come as GSK has agreed to sell its cephalosporins antibiotics business to Sandoz, a division of Swiss pharma firm Novartis, for as much as US$500m.

February 28, 2021

Colorcon launches TiO2-free supplement coating

Life sciences

“The launch of these new formulations provides the nutritional market with much-needed alternative coating systems that address clean label consumer preferences and are easy to implement,” says Kelly Boyer, vice president film coatings at Colorcon.

Send this to a friend